연구동향 분석

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?

김상진 박성열 정태융 유대선 박진성 조석 강석호 이상협 전승현 이춘용 2015년

논문상세정보
인용/피인용
' Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • gleasonscore
  • prostate-specific antigen
  • prostatic neoplasms
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,624 0

0.0%

' Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?' 의 참고문헌

  • What is ‘insignificant’ prostate carcinoma?
    Klein EA Cancer 101 : 1923 ~ 1925 [2004]
  • What is ‘insignificant’ prostate carcinoma?
    Klein EA Cancer 101 1923-1925 [2004]
  • Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
    Catalona WJ JAMA 279 : 1542 ~ 1547 [1998]
  • Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
    Catalona WJ JAMA 279 1542-1547 [1998]
  • The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance:a multi-institutional study
    McKenney JK J Urol 186 : 465 ~ 469 [2011]
  • The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance:a multi-institutional study
    McKenney JK J Urol 186 465-469 [2011]
  • The influence of finasteride on the development of prostate cancer
    Thompson IM N Engl J Med 349 : 215 ~ 224 [2003]
  • The influence of finasteride on the development of prostate cancer
    Thompson IM N Engl J Med 349 215-224 [2003]
  • The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma
    Brawer MK J Urol 150 (2 Pt 1) : 369 ~ 373 [1993]
  • The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma
    Brawer MK J Urol 150 2 Pt 1 369-373 [1993]
  • The changing pattern of prostate cancer at the time of diagnosis:characteristics of screen detected prostate cancer in a population based screening study
    Rietbergen JB J Urol 161 : 1192 ~ 1198 [1999]
  • The changing pattern of prostate cancer at the time of diagnosis:characteristics of screen detected prostate cancer in a population based screening study
    Rietbergen JB J Urol 161 1192-1198 [1999]
  • Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer
    Suardi N BJU Int 105 : 1548 ~ 1552 [2010]
  • Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer
    Suardi N BJU Int 105 1548-1552 [2010]
  • Repeat prostate biopsy: who, how and when?. a review
    Djavan B Eur Urol 42 : 93 ~ 103 [2002]
  • Repeat prostate biopsy: who, how and when?. a review
    Djavan B Eur Urol 42 93-103 [2002]
  • Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?
    Anast JW Urology 64 : 544 ~ 550 [2004]
  • Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population?
    Anast JW Urology 64 544-550 [2004]
  • Prostate carcinoma II: prognostic factors in prostate needle biopsies
    Montironi R BJU Int 97 : 492 ~ 497 [2006]
  • Prostate carcinoma II: prognostic factors in prostate needle biopsies
    Montironi R BJU Int 97 492-497 [2006]
  • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    D’Amico AV N Engl J Med 351 : 125 ~ 135 [2004]
  • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    D’Amico AV N Engl J Med 351 125-135 [2004]
  • Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program
    Bul M Eur Urol 61 : 370 ~ 377 [2012]
  • Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program
    Bul M Eur Urol 61 370-377 [2012]
  • Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance
    van As NJ Eur Urol 54 : 1297 ~ 1305 [2008]
  • Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance
    van As NJ Eur Urol 54 1297-1305 [2008]
  • Predicting 15-year prostate cancer specific mortality after radical prostatectomy
    Eggener SE J Urol 185 : 869 ~ 875 [2011]
  • Predicting 15-year prostate cancer specific mortality after radical prostatectomy
    Eggener SE J Urol 185 869-875 [2011]
  • Pathological outcomes of candidates for active surveillance of prostate cancer
    Conti SL J Urol 181 : 1628 ~ 1633 [2009]
  • Pathological outcomes of candidates for active surveillance of prostate cancer
    Conti SL J Urol 181 1628-1633 [2009]
  • Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
    Epstein JI JAMA 271 : 368 ~ 374 [1994]
  • Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
    Epstein JI JAMA 271 368-374 [1994]
  • Overdiagnosis in cancer
    Welch HG J Natl Cancer Inst 102 : 605 ~ 613 [2010]
  • Overdiagnosis in cancer
    Welch HG J Natl Cancer Inst 102 605-613 [2010]
  • Many young men with prostate-specific antigen (PSA) screendetected prostate cancers may be candidates for active surveillance
    Kim J BJU Int 111 : 934 ~ 940 [2013]
  • Many young men with prostate-specific antigen (PSA) screendetected prostate cancers may be candidates for active surveillance
    Kim J BJU Int 111 934-940 [2013]
  • Implications of PSA kinetics for an adverse pathology after radical prostatectomy
    Sfoungaristos S Asian Pac J Cancer Prev 12 : 1765 ~ 1769 [2011]
  • Implications of PSA kinetics for an adverse pathology after radical prostatectomy
    Sfoungaristos S Asian Pac J Cancer Prev 12 1765-1769 [2011]
  • Gleason grade progression is uncommon
    Penney KL Cancer Res 73 : 5163 ~ 5168 [2013]
  • Gleason grade progression is uncommon
    Penney KL Cancer Res 73 5163-5168 [2013]
  • Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort
    Smaldone MC J Urol 183 : 138 ~ 143 [2010]
  • Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort
    Smaldone MC J Urol 183 138-143 [2010]
  • Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies
    Kassouf W J Urol 178 : 111 ~ 114 [2007]
  • Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies
    Kassouf W J Urol 178 111-114 [2007]
  • Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
    D’Amico AV Cancer 95 : 281 ~ 286 [2002]
  • Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
    D’Amico AV Cancer 95 281-286 [2002]
  • Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial
    Thompson IM J Natl Cancer Inst 98 : 529 ~ 534 [2006]
  • Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial
    Thompson IM J Natl Cancer Inst 98 529-534 [2006]
  • Assessing individual risk for prostate cancer
    Nam RK J Clin Oncol 25 : 3582 ~ 3588 [2007]
  • Assessing individual risk for prostate cancer
    Nam RK J Clin Oncol 25 3582-3588 [2007]
  • An updated prostate cancer staging nomogram (Partin tables)based on cases from 2006 to 2011
    Eifler JB BJU Int 111 : 22 ~ 29 [2013]
  • An updated prostate cancer staging nomogram (Partin tables)based on cases from 2006 to 2011
    Eifler JB BJU Int 111 22-29 [2013]
  • An update of the Gleason grading system
    Epstein JI J Urol 183 : 433 ~ 440 [2010]
  • An update of the Gleason grading system
    Epstein JI J Urol 183 433-440 [2010]
  • Active surveillance versus surgery for low risk prostate cancer: a clinical decision analysis
    Liu D J Urol 187 : 1241 ~ 1246 [2012]
  • Active surveillance versus surgery for low risk prostate cancer: a clinical decision analysis
    Liu D J Urol 187 1241-1246 [2012]